To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NPDC1andFUT7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
566 supporting clones for gene NPDC1andFUT7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG819066 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1 to 550 1 to 551       551/552
(99 %)
12 diff
(97.9 %id)
BY797548 eye .a 7 to 540 1 to 534   tiling clone,   534/534
(100 %)
0 diff
(100 %id)
AW846047 colon .a 540 to 800 261 to 1       261/261
(100 %)
2 diff
(99.3 %id)
AW846049 colon .a 540 to 815 282 to 7   tiling clone,   276/282
(97 %)
0 diff
(100 %id)
CT001930 T-Lymphocytes .a 553 to 925 1 to 373       373/375
(99 %)
2 diff
(99.5 %id)
BG819053 anaplastic oligodendroglioma with 1p/19qloss, brain .a 670 to 1336 1 to 664   tiling clone,   664/664
(100 %)
6 diff
(99.1 %id)
BG741712 skin .a 801 to 1558 1 to 765   tiling clone,   765/765
(100 %)
12 diff
(98.5 %id)
AL353960 amygdala .a 853 to 1395 1 to 542       542/542
(100 %)
3 diff
(99.5 %id)
BQ712187 Spleen .a 1135 to 1803 13 to 684       672/980
(68 %)
19 diff
(98.1 %id)
BQ712634 Spleen .a 1142 to 1914 1 to 775       775/931
(83 %)
9 diff
(99.1 %id)
BQ712164 Spleen .a 1142 to 1912 1 to 778       778/925
(84 %)
19 diff
(98.0 %id)
AK054950 cerebellum .a 1355 to 3540 1 to 2186 R146* tiling clone, available from FLJ,   2186/2186
(100 %)
6 diff
(99.8 %id)
DA060062 cerebellum .a 1356 to 1920 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA088841 cerebellum .a 1363 to 1934 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG546875 lung .a 1381 to 1984 1 to 604       604/604
(100 %)
4 diff
(99.4 %id)
DA594540 lung .a 1415 to 1975 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BI554216 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1461 to 2314 1 to 843       843/849
(99 %)
23 diff
(97.3 %id)
TI_44384903   .a 1461 to 2314 95 to 937       843/849
(99 %)
23 diff
(97.3 %id)
BI554288 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1503 to 2080 51 to 653   AAA   603/1355
(44 %)
38 diff
(97.2 %id)
TI_44384993   .a 1503 to 2080 104 to 706   AAA   603/1355
(44 %)
38 diff
(97.2 %id)
DA265686 caudate nucleus .a 1592 to 2152 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
AL513716 placenta .a 1775 to 2761 1 to 983   fully sequenced,   983/983
(100 %)
10 diff
(99.0 %id)
CR597998 placenta .a 1775 to 3541 1 to 1767   tiling clone,   1767/1767
(100 %)
0 diff
(100 %id)
DR760485 embryonic stem .a 1985 to 2540 12 to 566       555/566
(98 %)
6 diff
(99.0 %id)
BM543830 ovary (pool of 3) .a 1992 to 2657 1 to 671       671/1202
(55 %)
14 diff
(98.9 %id)
BM853587 Ascites, stomach .a 2025 to 2234 1 to 210       210/210
(100 %)
3 diff
(98.6 %id)
CX871632 embryonic stem .a 2030 to 2782 1 to 753       753/753
(100 %)
2 diff
(99.8 %id)
BG696139 skin .a 2187 to 2770 1 to 587       587/716
(81 %)
15 diff
(98.0 %id)
BU150042 dorsal root ganglia .a 2221 to 2891 1 to 671       671/931
(72 %)
5 diff
(99.5 %id)
AL513715 placenta .a 2731 to 3541 808 to 1   fully sequenced,   808/808
(100 %)
10 diff
(98.8 %id)
DB296921 cerebellum .a 3007 to 3540 535 to 1       535/535
(100 %)
5 diff
(99.1 %id)
DA062456 cerebellum .b 1 to 507 2 to 508   tiling clone, capped   507/507
(100 %)
1 diff
(99.9 %id)
DA048007   .b 91 to 414 2 to 326   capped   325/325
(100 %)
2 diff
(99.4 %id)
DA871127 Prostate .b 91 to 660 2 to 571   tiling clone, capped   570/571
(99 %)
3 diff
(99.5 %id)
BM818644 stomach .b 142 to 666 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
CR621502 Neuroblastoma Cot 25-normalized .b 584 to 2028 1 to 1445 exact tiling clone,   1445/1445
(100 %)
0 diff
(100 %id)
BX375345 Neuroblastoma Cot 25-normalized .b 584 to 1408 1 to 824   fully sequenced,   824/824
(100 %)
1 diff
(99.9 %id)
BX443460 T cells (Jurkat cell line) .b 782 to 1051 796 to 1058       1056/1058
(99 %)
22 diff
(98.0 %id)
BX375344 Neuroblastoma Cot 25-normalized .b 1347 to 2028 683 to 1   fully sequenced,   683/683
(100 %)
11 diff
(98.4 %id)
BX414182 T cells (Jurkat cell line) .b 1462 to 2057 607 to 4       604/616
(98 %)
0 diff
(100 %id)
AW051375 pooled .b 1606 to 2055 456 to 7   tiling clone,   450/456
(98 %)
0 diff
(100 %id)
TI_154189088   .c 195 to 1034 29 to 862   tiling clone,   832/1055
(78 %)
14 diff
(98.7 %id)
CF126142 Chondrosarcoma Lung Metastasis cell lines, lung .c 206 to 1034 1 to 823   tiling clone,   823/824
(99 %)
8 diff
(99.1 %id)
BF529289 anaplastic oligodendroglioma with 1p/19qloss, brain .c 287 to 611 300 to 624       624/627
(99 %)
23 diff
(96.4 %id)
BC032357 Blood, adult leukocytes .d 1 to 1345 1 to 1345   tiling clone, available from MGC,   1345/1345
(100 %)
1 diff
(100.0 %id)
BI910687 leukocyte .d 2 to 781 1 to 779   available from MGC,   779/779
(100 %)
6 diff
(99.3 %id)
TI_57237600   .d 2 to 781 34 to 812       779/812
(95 %)
6 diff
(99.3 %id)
BU956231 adenocarcinoma, cell line, breast .d 167 to 696 86 to 620       535/1432
(37 %)
27 diff
(98.2 %id)
BC086312 Breast, adenocarcinoma .d 171 to 2584 1 to 2414 exact tiling clone, available from MGC, AAA   2414/2414
(100 %)
3 diff
(99.9 %id)
NM_004479.3   .d 171 to 2584 1 to 2414 exact RefSeq, AAA   2414/2414
(100 %)
0 diff
(100 %id)
BU860111 adenocarcinoma, cell line, breast .d 173 to 995 1 to 842       842/939
(89 %)
33 diff
(96.5 %id)
BU860455 adenocarcinoma, cell line, breast .d 173 to 899 1 to 749       749/884
(84 %)
38 diff
(95.8 %id)
DA955357 Spleen .d 506 to 1073 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA620866   .d 523 to 929 14 to 420   capped   407/419
(97 %)
7 diff
(98.4 %id)
AK313124 cord Blood .d 537 to 2048 1 to 1512 exact     1512/1512
(100 %)
1 diff
(100.0 %id)
DA433148 cord Blood .d 538 to 1086 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
U08112   .d 883 to 2208 1 to 1323 G161A P162S S163P P165L L166P ...     1323/1323
(100 %)
5 diff
(99.7 %id)
U11282   .d 883 to 2208 1 to 1326 exact     1326/1326
(100 %)
2 diff
(99.9 %id)
X78031   .d 898 to 2584 1 to 1687 exact tiling clone, AAA   1687/1687
(100 %)
1 diff
(100.0 %id)
DA008449 adipose .d 924 to 1392 2 to 471   capped   470/470
(100 %)
1 diff
(99.8 %id)
AW016469   .d 939 to 1352 414 to 1       414/426
(97 %)
1 diff
(99.8 %id)
AW135471   .d 939 to 1352 414 to 1       414/428
(96 %)
1 diff
(99.8 %id)
BX098574 germinal center B cell .d 940 to 1351 1 to 412       412/412
(100 %)
2 diff
(99.6 %id)
AW173123 pooled .d 972 to 1304 333 to 1       333/333
(100 %)
1 diff
(99.7 %id)
AA809620 germinal center B cell .d 978 to 1285 305 to 1       305/305
(100 %)
3 diff
(99.1 %id)
BC074746 Lung, PCR rescued clones .d 995 to 2095 1 to 1101 exact available from MGC,   1101/1101
(100 %)
0 diff
(100 %id)
BM798244 Ascites, stomach .d 1684 to 2046 1 to 363       363/363
(100 %)
2 diff
(99.5 %id)
DA065508 cerebellum .e 1 to 436 2 to 437   tiling clone, capped   436/436
(100 %)
0 diff
(100 %id)
DA058900 cerebellum .e 5 to 436 2 to 433   capped   432/436
(99 %)
1 diff
(99.8 %id)
DA059475 cerebellum .e 5 to 464 2 to 461   capped   460/460
(100 %)
1 diff
(99.8 %id)
DA091709 cerebellum .e 5 to 435 2 to 432   capped   431/431
(100 %)
0 diff
(100 %id)
DA205852 brain .e 5 to 514 2 to 511   tiling clone, capped   510/510
(100 %)
1 diff
(99.9 %id)
DA778245 brain .e 5 to 308 2 to 304   capped   303/303
(100 %)
1 diff
(99.7 %id)
DB022939 testis .e 5 to 514 2 to 511   capped   510/510
(100 %)
3 diff
(99.5 %id)
BF115543 fibrotheoma, ovary .e 29 to 318 1 to 290     Submitted on the opposite strand 290/290
(100 %)
1 diff
(99.7 %id)
BF207161 brain, neuroblastoma .e 475 to 1269 1 to 797       797/1001
(79 %)
29 diff
(97.2 %id)
BF315847 brain, neuroblastoma .e 475 to 1243 1 to 773       773/840
(92 %)
29 diff
(96.6 %id)
BF314648 brain, neuroblastoma .e 475 to 1233 1 to 761       761/1094
(69 %)
25 diff
(97.8 %id)
BI196097 brain, neuroblastoma .e 475 to 1191 1 to 721       721/723
(99 %)
5 diff
(99.4 %id)
NM_015392.3   .e 475 to 2002 1 to 1528 exact RefSeq, AAA   1528/1528
(100 %)
0 diff
(100 %id)
BI599614 brain, hypothalamus .e 478 to 1183 1 to 701       701/701
(100 %)
21 diff
(97.1 %id)
TI_45379599   .e 482 to 1124 51 to 693       643/695
(92 %)
7 diff
(99.0 %id)
TI_45379833   .e 482 to 1193 53 to 764       712/764
(93 %)
11 diff
(98.6 %id)
BP247413 Kidney .e 483 to 1063 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BI552532 brain, hippocampus .e 483 to 1161 1 to 684       684/685
(99 %)
18 diff
(97.4 %id)
TI_45213040   .e 483 to 1183 85 to 780       696/780
(89 %)
19 diff
(97.6 %id)
DA074368 cerebellum .e 484 to 791 2 to 309   capped   308/308
(100 %)
0 diff
(100 %id)
DB505466 hypothalamus .e 485 to 945 1 to 461       461/461
(100 %)
3 diff
(99.4 %id)
DA055191 cerebellum .e 487 to 718 2 to 234   capped   233/235
(99 %)
3 diff
(98.8 %id)
TI_44171187   .e 488 to 1161 127 to 805       679/806
(84 %)
16 diff
(98.1 %id)
BI604194 brain, hypothalamus .e 489 to 1174 1 to 687       687/694
(98 %)
12 diff
(98.3 %id)
TI_45213618   .e 491 to 1174 87 to 771       685/778
(88 %)
13 diff
(98.4 %id)
BP256406 Kidney .e 492 to 1071 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DA910699   .e 495 to 964 2 to 471   capped   470/470
(100 %)
2 diff
(99.6 %id)
DB034569 testis .e 495 to 1020 2 to 534   capped   533/533
(100 %)
9 diff
(98.4 %id)
AF285836 Liver .e 496 to 1988 1 to 1493 L159M Q210H tiling clone, AAA   1493/1493
(100 %)
3 diff
(99.8 %id)
BI488915 brain .e 497 to 1193 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
BI488809 brain .e 497 to 1124 1 to 628       628/630
(99 %)
1 diff
(99.9 %id)
BM548131 brain, hippocampus .e 498 to 1175 75 to 762       688/1234
(55 %)
25 diff
(98.0 %id)
BG697344 skin .e 500 to 1147 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BG700649 brain, hippocampus .e 500 to 1265 1 to 766       766/777
(98 %)
13 diff
(98.4 %id)
BI599042 brain, hypothalamus .e 500 to 1235 1 to 745       745/745
(100 %)
29 diff
(96.2 %id)
BF568133 epithelioid carcinoma cell line, Pancreas .e 501 to 1132 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
CR605121 Placenta Cot 25-normalized .e 502 to 1954 1 to 1453 exact     1453/1453
(100 %)
0 diff
(100 %id)
CR626507 T cells (Jurkat cell line) Cot10-normalized .e 502 to 1963 1 to 1462 exact     1462/1462
(100 %)
0 diff
(100 %id)
BX355641 Placenta Cot 25-normalized .e 502 to 1399 1 to 898   fully sequenced,   898/898
(100 %)
6 diff
(99.4 %id)
BX344491   .e 502 to 1408 1 to 902       902/905
(99 %)
12 diff
(98.7 %id)
TI_45215148   .e 505 to 1235 99 to 838       740/838
(88 %)
29 diff
(96.6 %id)
TI_57219662   .e 506 to 1158 54 to 704       651/704
(92 %)
11 diff
(98.5 %id)
TI_43964024   .e 506 to 1092 55 to 661       607/741
(81 %)
32 diff
(95.7 %id)
AW651699 cervical carcinoma cell line, cervix .e 507 to 953 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
BG707377 brain, hypothalamus .e 509 to 1138 9 to 642       634/660
(96 %)
21 diff
(96.9 %id)
BG501152 adenocarcinoma, Prostate .e 510 to 1094 1 to 591       591/599
(98 %)
20 diff
(96.7 %id)
DB498596 hypothalamus .e 511 to 1008 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
BF313281 brain, neuroblastoma .e 512 to 1161 1 to 637       637/737
(86 %)
21 diff
(97.2 %id)
BG475068 melanotic melanoma, skin .e 512 to 1068 1 to 566       566/1190
(47 %)
26 diff
(97.9 %id)
BI519987 brain, medulla .e 513 to 1092 1 to 600       600/680
(88 %)
38 diff
(94.5 %id)
BI752619 brain .e 513 to 1158 1 to 644       644/644
(100 %)
6 diff
(99.1 %id)
BM545925 ovary (pool of 3) .e 514 to 1175 69 to 739       671/1390
(48 %)
12 diff
(99.2 %id)
BX393604 Neuroblastoma Cot 10-normalized .e 517 to 1260 1 to 742       742/742
(100 %)
8 diff
(99.0 %id)
AL555353 placenta .e 517 to 1296 1 to 777   fully sequenced,   777/777
(100 %)
5 diff
(99.4 %id)
DT215154 brain .e 517 to 1233 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
DB477985 hippocampus .e 517 to 1015 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
DB505515 hypothalamus .e 517 to 965 1 to 449       449/449
(100 %)
1 diff
(99.8 %id)
BF966244 brain, hippocampus .e 517 to 1216 1 to 695   fully sequenced,   695/695
(100 %)
19 diff
(97.3 %id)
CR595396 HeLa cells Cot 25-normalized .e 518 to 1936 1 to 1419 exact     1419/1419
(100 %)
0 diff
(100 %id)
BF340062 brain, glioblastoma with EGFR amplification .e 520 to 1249 1 to 727       727/887
(81 %)
16 diff
(98.2 %id)
AK074793   .e 522 to 1996 1 to 1475 Q244R available from FLJ,   1475/1475
(100 %)
1 diff
(100.0 %id)
BP212499 cerebrum .e 522 to 1092 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BP212811 cerebrum .e 522 to 1101 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB482732 hippocampus .e 522 to 1021 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
CB153286 brain .e 523 to 964 1 to 442       442/442
(100 %)
0 diff
(100 %id)
BG913992 anaplastic oligodendroglioma with 1p/19qloss, brain .e 523 to 1155 1 to 633       633/637
(99 %)
8 diff
(98.8 %id)
DA126086 cerebellum .e 525 to 1104 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BG699239 brain, hippocampus .e 525 to 1335 1 to 803       803/854
(94 %)
29 diff
(96.7 %id)
DA696444   .e 525 to 1057 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA069425 cerebellum .e 528 to 950 2 to 424   capped   423/423
(100 %)
1 diff
(99.8 %id)
BI488493 brain .e 531 to 1276 1 to 761       759/802
(94 %)
39 diff
(95.2 %id)
TI_45378982   .e 531 to 1276 27 to 787       759/828
(91 %)
37 diff
(95.6 %id)
CR621251 Neuroblastoma Cot 50-normalized .e 532 to 1960 1 to 1429 exact     1429/1429
(100 %)
0 diff
(100 %id)
AL530333 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 532 to 1400 1 to 866   fully sequenced,   866/866
(100 %)
7 diff
(99.2 %id)
BP253497 Kidney .e 535 to 1115 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA113918 cerebellum .e 536 to 1111 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AL521468 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 538 to 1411 1 to 872       872/872
(100 %)
5 diff
(99.5 %id)
BX366082 Neuroblastoma Cot 10-normalized .e 538 to 1392 1 to 857       857/857
(100 %)
4 diff
(99.6 %id)
CA392783 eye, RPE/choroid .e 542 to 1101 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AF327349   .e 543 to 1994 1 to 1452 A40T AAA   1452/1452
(100 %)
2 diff
(99.9 %id)
BE314276 brain, neuroblastoma .e 558 to 1143 1 to 583       583/676
(86 %)
8 diff
(98.9 %id)
BE799574 lung, small cell carcinoma .e 560 to 1267 28 to 731       704/823
(85 %)
24 diff
(97.1 %id)
BF314941 brain, neuroblastoma .e 561 to 1300 1 to 722       724/938
(77 %)
25 diff
(97.4 %id)
BF313764 brain, neuroblastoma .e 561 to 1369 1 to 802       802/822
(97 %)
22 diff
(97.4 %id)
BF347594 anaplastic oligodendroglioma with 1p/19qloss, brain .e 562 to 1254 1 to 689       689/946
(72 %)
32 diff
(96.7 %id)
BI918762 brain .e 563 to 1331 30 to 799       770/872
(88 %)
20 diff
(97.8 %id)
BM544863 ovary (pool of 3) .e 563 to 1339 12 to 789       778/1187
(65 %)
17 diff
(98.6 %id)
TI_57241144   .e 563 to 1331 30 to 799       770/872
(88 %)
20 diff
(97.8 %id)
BP211072 cerebellum .e 565 to 1145 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
AI878983 brain, frontal lobe .e 565 to 1054 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BG480256 choriocarcinoma, placenta .e 567 to 1194 1 to 629       629/630
(99 %)
4 diff
(99.4 %id)
BF528979 anaplastic oligodendroglioma with 1p/19qloss, brain .e 570 to 1160 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
BQ941409 sciatic nerve .e 571 to 1160 1 to 596       596/973
(61 %)
27 diff
(97.3 %id)
CF126166 Chondrosarcoma Lung Metastasis cell lines, lung .e 571 to 1358 1 to 789       789/789
(100 %)
3 diff
(99.7 %id)
TI_154189116   .e 571 to 1420 51 to 902       852/1027
(82 %)
9 diff
(99.2 %id)
BG747604 eye, normal pigmented retinal epithelium .e 573 to 1233 1 to 663       661/663
(99 %)
11 diff
(98.4 %id)
AW163049 brain, frontal lobe .e 579 to 979 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BP265898 thyroid .e 579 to 1156 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BP266193 thyroid .e 579 to 1140 1 to 562       562/573
(98 %)
1 diff
(99.9 %id)
CR618636 HeLa cells Cot 25-normalized .e 582 to 1932 1 to 1351 exact     1351/1351
(100 %)
0 diff
(100 %id)
BX386679   .e 582 to 1661 1 to 1072       1074/1097
(97 %)
14 diff
(98.8 %id)
BX400970   .e 582 to 1560 1 to 969       969/996
(97 %)
20 diff
(98.0 %id)
BG325648 Kidney, renal cell adenocarcinoma .e 583 to 1261 1 to 675       675/729
(92 %)
14 diff
(98.1 %id)
BG478381 melanotic melanoma, skin .e 583 to 1308 1 to 742       742/882
(84 %)
35 diff
(96.1 %id)
BE262566 brain, neuroblastoma .e 587 to 1248 10 to 673       664/742
(89 %)
26 diff
(96.5 %id)
BG680560 skin, squamous cell carcinoma .e 588 to 1461 1 to 870       872/871
(100 %)
30 diff
(96.6 %id)
BG699084 brain, hippocampus .e 588 to 1249 1 to 663       663/663
(100 %)
6 diff
(99.1 %id)
BF530286 anaplastic oligodendroglioma with 1p/19qloss, brain .e 590 to 1249 10 to 662       653/730
(89 %)
23 diff
(96.9 %id)
BI914357 brain .e 590 to 1407 1 to 820       820/820
(100 %)
17 diff
(98.0 %id)
TI_57242963   .e 590 to 1407 34 to 853       820/853
(96 %)
22 diff
(97.5 %id)
BC004217 Kidney, renal cell adenocarcinoma .e 591 to 2002 1 to 1412 exact tiling clone, available from MGC, AAA   1412/1412
(100 %)
0 diff
(100 %id)
BI838413 pooled pancreas and spleen .e 591 to 1249 1 to 658       658/658
(100 %)
12 diff
(98.2 %id)
TI_57163052   .e 591 to 1249 30 to 687       658/687
(95 %)
17 diff
(97.6 %id)
BG764844 melanotic melanoma, high MDR (cell line), skin .e 600 to 1498 1 to 893       889/963
(92 %)
28 diff
(97.1 %id)
BI261128 cervical carcinoma cell line, cervix .e 604 to 1153 46 to 602       557/602
(92 %)
17 diff
(97.2 %id)
DR006056 Prostate .e 605 to 1345 8 to 748       741/748
(99 %)
6 diff
(99.2 %id)
CA487635   .e 606 to 1180 1 to 576       576/1090
(52 %)
22 diff
(98.0 %id)
BI257864 cervical carcinoma cell line, cervix .e 607 to 1349 1 to 747       747/747
(100 %)
14 diff
(98.2 %id)
BE272500 Kidney, renal cell adenocarcinoma .e 611 to 1135 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
CB215296 normal endometrium, late proliferativephase, cycle day 13, uterus .e 612 to 1136 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
CN483234 eye .e 614 to 1231 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BI916087 brain .e 615 to 1429 1 to 829       767/1047
(73 %)
32 diff
(97.0 %id)
CB988891 Human Placenta, placenta .e 615 to 1235 24 to 652       629/916
(68 %)
24 diff
(97.4 %id)
CD109934 Human Placenta, placenta .e 615 to 1235 24 to 659       638/832
(76 %)
48 diff
(94.3 %id)
BQ928660 carcinoma, cell line, Prostate .e 619 to 1266 26 to 681       656/1056
(62 %)
29 diff
(97.3 %id)
BU543678 carcinoma, cell line, Prostate .e 620 to 1256 1 to 640       640/1029
(62 %)
13 diff
(98.8 %id)
DB476163 hippocampus .e 621 to 1105 1 to 485       485/485
(100 %)
0 diff
(100 %id)
DB476376 hippocampus .e 621 to 1106 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
BQ050832 leiomyosarcoma, uterus .e 627 to 1262 1 to 639       639/1223
(52 %)
7 diff
(99.5 %id)
DR762057 embryonic stem .e 627 to 1358 1 to 732       732/732
(100 %)
1 diff
(99.9 %id)
AF272357 Iris .e 628 to 1988 1 to 1361 H113Q AAA   1361/1361
(100 %)
1 diff
(100.0 %id)
BF338232 brain, glioblastoma with EGFR amplification .e 628 to 1143 1 to 518       518/1056
(49 %)
5 diff
(99.6 %id)
BQ890477 dorsal root ganglia .e 628 to 1397 1 to 775       775/965
(80 %)
22 diff
(97.8 %id)
BQ680543 melanotic melanoma, cell line, skin .e 629 to 1194 1 to 568       568/1030
(55 %)
11 diff
(99.0 %id)
TI_154194739   .e 630 to 1417 48 to 830       783/1040
(75 %)
14 diff
(98.7 %id)
BI198540 brain, neuroblastoma .e 634 to 1161 1 to 531       531/532
(99 %)
5 diff
(99.1 %id)
BQ941283 sciatic nerve .e 639 to 1270 40 to 673       634/994
(63 %)
18 diff
(98.2 %id)
BE311751 Kidney, renal cell adenocarcinoma .e 640 to 1175 1 to 541       541/584
(92 %)
10 diff
(98.3 %id)
BM920813 pooled brain, lung, testis .e 643 to 1257 1 to 619       619/1390
(44 %)
9 diff
(99.4 %id)
CD108209 brain, Pituitary .e 648 to 1412 1 to 769       769/867
(88 %)
19 diff
(97.9 %id)
BF678944 Prostate .e 654 to 1248 1 to 587       587/880
(66 %)
20 diff
(97.8 %id)
AK225091 coronary artery .e 672 to 1988 1 to 1320 A27G L29A R30L G31R A32G ... AAA   1320/1320
(100 %)
2 diff
(99.9 %id)
BP206813 coronary artery .e 672 to 1248 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
AF283247 brain .e 822 to 1996 1 to 1173   AAA   1173/1173
(100 %)
6 diff
(99.5 %id)
BX376284 Neuroblastoma Cot 25-normalized .e 955 to 1134 1 to 180   fully sequenced,   180/180
(100 %)
0 diff
(100 %id)
CA488097   .e 958 to 1637 1 to 683       683/954
(71 %)
12 diff
(98.8 %id)
BX386678   .e 963 to 1932 967 to 1       967/967
(100 %)
25 diff
(97.5 %id)
CR619157 Neuroblastoma Cot 25-normalized .e 965 to 1940 1 to 976       976/976
(100 %)
0 diff
(100 %id)
BQ581262 insulinoma, Pancreas .e 967 to 1528 1 to 562   fully sequenced,   562/562
(100 %)
4 diff
(99.3 %id)
BX421028 brain, fetal brain .e 988 to 1977 990 to 1       990/990
(100 %)
20 diff
(98.0 %id)
BQ923717 sciatic nerve .e 1023 to 1738 1 to 733       733/1123
(65 %)
26 diff
(97.7 %id)
BX344490   .e 1026 to 1963 935 to 1       933/942
(99 %)
25 diff
(97.4 %id)
BF316117 brain, neuroblastoma .e 1030 to 1721 1 to 691       693/691
(100 %)
28 diff
(96.0 %id)
BI197232 brain, neuroblastoma .e 1030 to 1719 1 to 690       690/693
(99 %)
2 diff
(99.8 %id)
BI198441 brain, neuroblastoma .e 1030 to 1721 1 to 694       694/695
(99 %)
24 diff
(96.6 %id)
CX761507 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 1031 to 1736 1 to 700       700/840
(83 %)
10 diff
(98.9 %id)
TI_154056922   .e 1038 to 1993 1024 to 85   AAA   940/986
(95 %)
26 diff
(97.4 %id)
AL561993.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 1068 to 1962 894 to 1     also hits gene MVK 894/894
(100 %)
2 diff
(99.8 %id)
BM927968 hepatocellular carcinoma, cell line, Liver .e 1068 to 1749 1 to 687       687/977
(70 %)
9 diff
(99.1 %id)
BU502523 carcinoma, cell line, Prostate .e 1075 to 1854 1 to 798       798/971
(82 %)
31 diff
(96.9 %id)
BM172129 large cell carcinoma, lung .e 1085 to 1803 10 to 728       719/728
(98 %)
18 diff
(97.6 %id)
CR595553 Neuroblastoma Cot 25-normalized .e 1095 to 1995 1 to 902       902/902
(100 %)
1 diff
(99.9 %id)
AL523472 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1095 to 1995 1 to 901   fully sequenced,   901/901
(100 %)
11 diff
(98.8 %id)
BI117694 lung, small cell carcinoma .e 1099 to 1835 1 to 739       739/740
(99 %)
23 diff
(96.9 %id)
BX376283 Neuroblastoma Cot 25-normalized .e 1104 to 1931 832 to 10   fully sequenced,   823/832
(98 %)
11 diff
(98.7 %id)
BM822565 stomach .e 1108 to 1683 1 to 576       576/576
(100 %)
0 diff
(100 %id)
TI_159723785   .e 1159 to 1988 923 to 94   AAA   830/1011
(82 %)
10 diff
(99.1 %id)
BQ677965 melanotic melanoma, cell line, skin .e 1179 to 1993 1 to 821       821/987
(83 %)
62 diff
(93.8 %id)
BF966904 brain, hippocampus .e 1186 to 1955 807 to 42   fully sequenced,   766/807
(94 %)
13 diff
(98.4 %id)
BG474269 eye, retinoblastoma .e 1197 to 1735 1 to 539       539/539
(100 %)
3 diff
(99.5 %id)
AA480091 ovarian tumor, ovary .e 1214 to 1739 1 to 522       524/522
(100 %)
9 diff
(98.3 %id)
AL577877 placenta .e 1235 to 1936 702 to 1   fully sequenced,   702/702
(100 %)
3 diff
(99.6 %id)
BM807533 brain, hippocampus .e 1243 to 1985 19 to 763       745/1189
(62 %)
21 diff
(98.3 %id)
AI879485 brain, frontal lobe .e 1247 to 1715 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AW157080 brain, frontal lobe .e 1250 to 1690 441 to 1       441/441
(100 %)
0 diff
(100 %id)
BQ072055 brain, neuroblastoma, cell line .e 1266 to 1993 749 to 21   AAA Submitted on the opposite strand 729/1054
(69 %)
18 diff
(98.3 %id)
BU607324 Human Lung Epithelial cells, lung .e 1266 to 1994 747 to 19   AAA   729/729
(100 %)
1 diff
(99.9 %id)
BQ014338 Chondrosarcoma, Left Pubic Bone .e 1268 to 1988 737 to 17   AAA   721/721
(100 %)
1 diff
(99.9 %id)
CB242775 Human Lung Epithelial cells, lung .e 1272 to 1988 733 to 17   AAA   717/717
(100 %)
0 diff
(100 %id)
CN479018 Human Lung Epithelial cells, lung .e 1272 to 1990 735 to 17   AAA   719/719
(100 %)
1 diff
(99.9 %id)
AI951795 brain, four pooled pituitary adenomas .e 1274 to 1996 724 to 2       723/724
(99 %)
8 diff
(98.9 %id)
BI045522 prostate_normal .e 1282 to 1642 1 to 360       360/367
(98 %)
6 diff
(98.4 %id)
CN310503 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1282 to 1831 1 to 550       550/550
(100 %)
0 diff
(100 %id)
AI361036 brain, glioblastoma (pooled) .e 1283 to 1994 712 to 2       711/712
(99 %)
14 diff
(98.1 %id)
BQ008502 Chondrosarcoma, Left Pubic Bone .e 1284 to 1990 723 to 17   AAA   707/707
(100 %)
1 diff
(99.9 %id)
AI799722 anaplastic oligodendroglioma, brain .e 1289 to 1993 706 to 1       706/706
(100 %)
3 diff
(99.6 %id)
AI805156 pooled .e 1300 to 1993 698 to 5       694/700
(99 %)
15 diff
(97.9 %id)
AI800618 pooled .e 1300 to 1989 694 to 4       691/696
(99 %)
1 diff
(99.9 %id)
AA040108 uterus .e 1323 to 1540 1 to 217       217/217
(100 %)
1 diff
(99.6 %id)
AA044254 uterus .e 1323 to 1679 1 to 357   fully sequenced,   359/359
(100 %)
6 diff
(98.4 %id)
AI569988 adenocarcinoma, Pancreas .e 1330 to 1996 690 to 35   AAA   656/710
(92 %)
45 diff
(93.7 %id)
AI888307 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1330 to 1995 666 to 1       666/671
(99 %)
8 diff
(98.9 %id)
BF476717 sympathetic trunk .e 1330 to 1993 664 to 1       664/666
(99 %)
4 diff
(99.4 %id)
TI_149299239   .e 1337 to 1996 780 to 128   AAA   651/722
(90 %)
70 diff
(90.4 %id)
BU857985 adenocarcinoma, cell line, breast .e 1344 to 1986 1 to 643   AAA   643/643
(100 %)
1 diff
(99.9 %id)
W57690 heart .e 1349 to 1621 1 to 271       273/271
(100 %)
7 diff
(97.5 %id)
BG683532 brain, neuroblastoma, cell line .e 1357 to 1950 593 to 3       591/593
(99 %)
0 diff
(100 %id)
AL050221 uterus .e 1358 to 1988 1 to 630   available from DKFZ, AAA   630/630
(100 %)
1 diff
(99.9 %id)
BX355640 Placenta Cot 25-normalized .e 1369 to 1954 586 to 1   fully sequenced,   586/586
(100 %)
3 diff
(99.5 %id)
BQ448214 Knee, Osteoarthritic Cartilage .e 1369 to 1988 636 to 17   AAA   620/620
(100 %)
2 diff
(99.7 %id)
AL563711 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 1370 to 1957 595 to 5   fully sequenced,   591/595
(99 %)
4 diff
(99.4 %id)
AI683381 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1373 to 1990 618 to 2       617/618
(99 %)
12 diff
(98.1 %id)
CA444252 lung, Metastatic Chondrosarcoma .e 1378 to 1996 638 to 19   AAA   620/620
(100 %)
2 diff
(99.7 %id)
AI889480 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1386 to 1992 607 to 1       607/632
(96 %)
8 diff
(98.8 %id)
BF435522 sciatic nerve .e 1391 to 1996 607 to 3       605/607
(99 %)
6 diff
(99.1 %id)
BM172144 brain, neuroblastoma, cell line .e 1402 to 1993 622 to 31   AAA Submitted on the opposite strand 592/592
(100 %)
14 diff
(97.7 %id)
TI_151771562   .e 1408 to 1970 103 to 663       561/896
(62 %)
54 diff
(94.0 %id)
CA312110 Human Lung Epithelial cells, lung .e 1416 to 1996 599 to 19   AAA   581/581
(100 %)
0 diff
(100 %id)
AW593199 pooled .e 1417 to 1993 580 to 4       577/597
(96 %)
8 diff
(98.7 %id)
AW612912 colon, moderately-differentiated adenocarcinoma .e 1417 to 2001 593 to 9       585/616
(94 %)
13 diff
(97.9 %id)
BE047119 squamous cell carcinoma, tongue .e 1417 to 1988 572 to 1       572/577
(99 %)
9 diff
(98.5 %id)
BF195662 fibrotheoma, ovary .e 1417 to 1996 583 to 4       580/600
(96 %)
14 diff
(97.7 %id)
H46483 brain .e 1418 to 1756 337 to 1     Submitted on the opposite strand 337/390
(86 %)
18 diff
(95.4 %id)
BQ575630 Chondrosarcoma Grade II, Left Pelvis .e 1422 to 1993 590 to 19   AAA   572/572
(100 %)
0 diff
(100 %id)
AA621805 colon, colon tumor RER+ .e 1424 to 1987 570 to 8       563/570
(98 %)
2 diff
(99.7 %id)
BF346663 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1429 to 1996 1 to 569       569/588
(96 %)
4 diff
(99.4 %id)
BF343191 brain, glioblastoma with EGFR amplification .e 1433 to 1996 1 to 564   AAA   564/564
(100 %)
2 diff
(99.7 %id)
AI289074 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1434 to 1988 555 to 1       555/556
(99 %)
17 diff
(97.0 %id)
AA069342 pineal gland .e 1436 to 1624 1 to 187   fully sequenced,   189/189
(100 %)
5 diff
(97.4 %id)
AI801367 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1436 to 1993 559 to 2       558/559
(99 %)
0 diff
(100 %id)
BM671234 eye, optic nerve .e 1436 to 2000 583 to 19   AAA   565/565
(100 %)
3 diff
(99.5 %id)
CA431408 cell lines, Enchondroma .e 1439 to 1995 575 to 19   AAA   557/559
(99 %)
4 diff
(99.3 %id)
CA311700 Human Lung Epithelial cells, lung .e 1443 to 1988 562 to 17   AAA   546/546
(100 %)
4 diff
(99.3 %id)
AA877657 colon, colon tumor RER+ .e 1448 to 2000 577 to 31   AAA   551/547
(100 %)
18 diff
(96.8 %id)
AW338273 adenocarcinoma, Pancreas .e 1451 to 1994 545 to 2       544/545
(99 %)
5 diff
(99.1 %id)
BF094749 uterus_tumor .e 1456 to 1775 10 to 332       279/332
(84 %)
20 diff
(94.0 %id)
AA877463 2 pooled tumors (clear cell type), Kidney .e 1457 to 1993 539 to 5       535/539
(99 %)
15 diff
(97.3 %id)
AI683749 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1457 to 1995 539 to 2       538/539
(99 %)
6 diff
(98.9 %id)
AW673160 cervical carcinoma cell line, cervix .e 1457 to 1996 541 to 1       541/545
(99 %)
5 diff
(99.1 %id)
BQ614596 insulinoma, Pancreas .e 1457 to 1988 557 to 26   AAA Submitted on the opposite strand 532/532
(100 %)
4 diff
(99.3 %id)
AW604489 colon .e 1460 to 1649 8 to 197       190/211
(90 %)
14 diff
(93.4 %id)
BG056125 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .e 1460 to 1996 538 to 2       537/538
(99 %)
6 diff
(98.9 %id)
BF092351 testis_normal .e 1462 to 1774 316 to 3       314/319
(98 %)
2 diff
(99.4 %id)
BF092531 testis_normal .e 1462 to 1775 1 to 310       312/310
(100 %)
13 diff
(95.9 %id)
BF092540 testis_normal .e 1462 to 1722 266 to 1       266/270
(98 %)
15 diff
(94.5 %id)
AI742494 pooled .e 1463 to 1989 530 to 4       527/530
(99 %)
1 diff
(99.9 %id)
BF094617 uterus_tumor .e 1464 to 1784 347 to 22       326/354
(92 %)
2 diff
(99.5 %id)
BF888222 testis_normal .e 1464 to 1775 8 to 316       309/316
(97 %)
11 diff
(96.6 %id)
BM792890 Ascites, stomach .e 1464 to 1977 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
AL523471 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1467 to 1982 516 to 1   fully sequenced,   516/516
(100 %)
11 diff
(97.9 %id)
BQ549415 insulinoma, Pancreas .e 1467 to 1995 544 to 16   fully sequenced, AAA   529/529
(100 %)
3 diff
(99.5 %id)
BF092333 testis_normal .e 1470 to 1775 1 to 306       306/306
(100 %)
4 diff
(98.7 %id)
BF094798 uterus_tumor .e 1471 to 1775 33 to 340       308/340
(90 %)
22 diff
(93.6 %id)
BF092373 testis_normal .e 1472 to 1774 314 to 7       308/314
(98 %)
0 diff
(100 %id)
BF092386 testis_normal .e 1472 to 1813 354 to 15       340/354
(96 %)
1 diff
(99.8 %id)
BF092398 testis_normal .e 1472 to 1768 309 to 15       295/309
(95 %)
1 diff
(99.7 %id)
BF092564 testis_normal .e 1472 to 1776 308 to 2       307/308
(99 %)
0 diff
(100 %id)
BF092567 testis_normal .e 1472 to 1815 347 to 4       344/347
(99 %)
0 diff
(100 %id)
BF092571 testis_normal .e 1472 to 1776 308 to 6       303/308
(98 %)
0 diff
(100 %id)
BF092579 testis_normal .e 1472 to 1815 355 to 10       346/355
(97 %)
2 diff
(99.5 %id)
BF094557 uterus_tumor .e 1472 to 1768 301 to 6       296/301
(98 %)
0 diff
(100 %id)
BF094619 uterus_tumor .e 1472 to 1775 1 to 304       304/304
(100 %)
1 diff
(99.7 %id)
BF094666 uterus_tumor .e 1472 to 1775 1 to 304       304/304
(100 %)
1 diff
(99.7 %id)
BF094744 uterus_tumor .e 1472 to 1767 302 to 7       296/302
(98 %)
0 diff
(100 %id)
BF094832 uterus_tumor .e 1472 to 1784 348 to 39       310/348
(89 %)
0 diff
(100 %id)
BF377293 testis_normal .e 1472 to 1717 314 to 66       249/314
(79 %)
0 diff
(100 %id)
BF380190 uterus_tumor .e 1472 to 1775 1 to 304       304/304
(100 %)
1 diff
(99.7 %id)
BF888230 testis_normal .e 1472 to 1781 314 to 6     Submitted on the opposite strand 309/314
(98 %)
0 diff
(100 %id)
BF912620 uterus_tumor .e 1472 to 1784 318 to 6     Submitted on the opposite strand 313/318
(98 %)
0 diff
(100 %id)
BF912623 uterus_tumor .e 1472 to 1771 303 to 4     Submitted on the opposite strand 300/303
(99 %)
0 diff
(100 %id)
BQ374890 testis_normal .e 1472 to 1774 311 to 8       304/311
(97 %)
0 diff
(100 %id)
AI811191 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 1472 to 1995 528 to 7       524/528
(99 %)
9 diff
(98.3 %id)
AI926831 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1472 to 1993 527 to 4       524/527
(99 %)
9 diff
(98.3 %id)
BQ301621 bocio_tumor .e 1477 to 1679 1 to 202       204/202
(100 %)
2 diff
(99.1 %id)
BF092536 testis_normal .e 1478 to 1803 1 to 326       326/344
(94 %)
5 diff
(98.6 %id)
BF092756 testis_normal .e 1479 to 1784 20 to 327       310/331
(93 %)
13 diff
(96.1 %id)
W32237 heart .e 1479 to 1675 1 to 194       198/196
(101 %)
15 diff
(92.4 %id)
AI921223 adenocarcinoma, Pancreas .e 1491 to 1989 498 to 1       498/504
(98 %)
6 diff
(98.9 %id)
BP383921 pancreatic islet .e 1493 to 1987 1 to 495     Submitted on the opposite strand 495/500
(99 %)
1 diff
(99.8 %id)
BP394208 pancreatic islet .e 1494 to 1994 1 to 501     Submitted on the opposite strand 501/501
(100 %)
1 diff
(99.9 %id)
BP392383 pancreatic islet .e 1495 to 1994 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
AI761161 colon, colon tumor, RER+ .e 1496 to 1652 157 to 1       157/157
(100 %)
5 diff
(96.9 %id)
BG222535 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .e 1496 to 1989 500 to 1       500/500
(100 %)
6 diff
(98.8 %id)
DB569668 hypothalamus .e 1497 to 2002 22 to 527     Submitted on the opposite strand 506/527
(96 %)
7 diff
(98.7 %id)
AA609522   .e 1497 to 1991 497 to 4       494/498
(99 %)
1 diff
(99.8 %id)
AI569761 anaplastic oligodendroglioma, brain .e 1497 to 1995 499 to 1       499/521
(95 %)
3 diff
(99.5 %id)
AW150866 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1497 to 1993 534 to 39       496/584
(84 %)
15 diff
(97.5 %id)
BF092407 testis_normal .e 1498 to 1775 1 to 277       277/277
(100 %)
13 diff
(95.4 %id)
BP389536 pancreatic islet .e 1498 to 1994 1 to 496     Submitted on the opposite strand 496/500
(99 %)
3 diff
(99.4 %id)
AA661720 normal prostate, Prostate .e 1499 to 1998 520 to 18   AAA   503/518
(97 %)
24 diff
(95.4 %id)
BF092538 testis_normal .e 1500 to 1784 34 to 320       285/324
(87 %)
7 diff
(97.9 %id)
AI889033 anaplastic oligodendroglioma, brain .e 1502 to 1996 511 to 17   AAA   495/495
(100 %)
9 diff
(98.2 %id)
AW591212 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 1502 to 1996 506 to 12   AAA   495/495
(100 %)
14 diff
(97.2 %id)
BF092541 testis_normal .e 1503 to 1775 11 to 285       275/285
(96 %)
7 diff
(97.6 %id)
AA435740.
matches multiple genes
  .e 1503 to 1996 500 to 7     also hits gene NSUN4andFAAH 494/500
(98 %)
1 diff
(99.8 %id)
AW243932 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1503 to 1996 495 to 1       495/600
(82 %)
11 diff
(98.2 %id)
BE138911 adenocarcinoma, Pancreas .e 1506 to 1984 493 to 5       489/495
(98 %)
21 diff
(95.8 %id)
BX393603 Neuroblastoma Cot 10-normalized .e 1507 to 1967 463 to 2       462/463
(99 %)
14 diff
(97.0 %id)
DB544491 hippocampus .e 1507 to 1995 1 to 489     Submitted on the opposite strand 489/489
(100 %)
1 diff
(99.8 %id)
BP384846 pancreatic islet .e 1507 to 1995 1 to 489     Submitted on the opposite strand 489/497
(98 %)
1 diff
(99.8 %id)
BX413842 brain, fetal brain .e 1508 to 1991 489 to 5       485/595
(81 %)
9 diff
(98.5 %id)
AI581035 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1509 to 1993 490 to 6       485/491
(98 %)
2 diff
(99.6 %id)
BU948397 insulinoma, Pancreas .e 1510 to 1968 8 to 467   fully sequenced,   460/467
(98 %)
10 diff
(97.9 %id)
AW955234   .e 1511 to 1987 478 to 1     Submitted on the opposite strand 478/478
(100 %)
21 diff
(95.7 %id)
DB576793 hypothalamus .e 1512 to 1994 1 to 482     Submitted on the opposite strand 482/482
(100 %)
5 diff
(99.0 %id)
AI433980 adenocarcinoma, Pancreas .e 1516 to 1996 520 to 40   AAA   481/483
(99 %)
5 diff
(99.0 %id)
BM694730 eye, RPE and Choroid .e 1520 to 1920 1 to 401       401/401
(100 %)
2 diff
(99.6 %id)
DB576742 hypothalamus .e 1522 to 1994 1 to 473     Submitted on the opposite strand 473/473
(100 %)
3 diff
(99.4 %id)
DB568553 hypothalamus .e 1527 to 1992 1 to 466     Submitted on the opposite strand 466/468
(99 %)
2 diff
(99.6 %id)
AI498981 anaplastic oligodendroglioma, brain .e 1527 to 1995 470 to 2       469/471
(99 %)
3 diff
(99.4 %id)
DB545135 hippocampus .e 1529 to 1988 1 to 460     Submitted on the opposite strand 460/460
(100 %)
2 diff
(99.6 %id)
AI598080 adenocarcinoma, Pancreas .e 1531 to 1995 474 to 10       465/474
(98 %)
0 diff
(100 %id)
DB542555 hippocampus .e 1535 to 1994 1 to 460     Submitted on the opposite strand 460/462
(99 %)
2 diff
(99.6 %id)
AI369785 anaplastic oligodendroglioma, brain .e 1535 to 1988 454 to 1       454/454
(100 %)
3 diff
(99.4 %id)
AI858952 anaplastic oligodendroglioma, brain .e 1542 to 1993 453 to 2       452/454
(99 %)
0 diff
(100 %id)
DB538836 hippocampus .e 1543 to 1986 1 to 444     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
BF222275 Prostate .e 1550 to 1993 444 to 1       444/444
(100 %)
0 diff
(100 %id)
DB553335 hypothalamus .e 1555 to 1994 1 to 441     Submitted on the opposite strand 441/441
(100 %)
9 diff
(98.0 %id)
BU948126 insulinoma, Pancreas .e 1564 to 1993 447 to 18   fully sequenced, AAA   430/430
(100 %)
1 diff
(99.8 %id)
AI370294 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1565 to 1996 441 to 10       432/441
(97 %)
1 diff
(99.8 %id)
DB547270 hippocampus .e 1568 to 1995 1 to 428     Submitted on the opposite strand 428/428
(100 %)
2 diff
(99.6 %id)
AA847765 colon, colon tumor .e 1571 to 1996 440 to 14   AAA   427/429
(99 %)
16 diff
(96.3 %id)
AI805420 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1571 to 1989 421 to 3       419/421
(99 %)
0 diff
(100 %id)
BG180787 adenocarcinoma, cell line, Prostate .e 1571 to 1993 1 to 423   AAA   423/423
(100 %)
1 diff
(99.8 %id)
AA069343 pineal gland .e 1572 to 1993 452 to 24   fully sequenced,   429/452
(94 %)
0 diff
(100 %id)
AI826358 normal prostate, Prostate .e 1580 to 2000 437 to 16   AAA   422/422
(100 %)
13 diff
(97.0 %id)
AW192450 adenocarcinoma, Pancreas .e 1580 to 1993 414 to 1       414/414
(100 %)
13 diff
(96.9 %id)
AI358099 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1589 to 1994 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI678478 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1589 to 1989 405 to 5       401/405
(99 %)
0 diff
(100 %id)
DB530823 hippocampus .e 1594 to 1991 24 to 424     Submitted on the opposite strand 401/424
(94 %)
6 diff
(98.6 %id)
AA040109 uterus .e 1594 to 1995 413 to 1       413/430
(96 %)
17 diff
(96.1 %id)
AA773192 lung, lung carcinoma .e 1594 to 1996 406 to 7       400/407
(98 %)
0 diff
(100 %id)
AI094479 brain, glioblastoma (pooled) .e 1594 to 1990 403 to 10       394/404
(97 %)
0 diff
(100 %id)
AI433260 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1594 to 1995 413 to 12   AAA   402/403
(99 %)
2 diff
(99.6 %id)
AI936090 normal prostate, Prostate .e 1594 to 1987 419 to 26       394/424
(92 %)
0 diff
(100 %id)
AW769427 colon, moderately-differentiated adenocarcinoma .e 1596 to 1996 408 to 8       401/409
(98 %)
0 diff
(100 %id)
BM479210 duodenal adenocarcinoma, cell line, small intestine .e 1597 to 1994 1 to 398   AAA   398/398
(100 %)
0 diff
(100 %id)
AI969161 brain, four pooled pituitary adenomas .e 1598 to 1994 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AI624185 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1604 to 1996 397 to 6       392/397
(98 %)
0 diff
(100 %id)
EC544339 Prostate .e 1605 to 1702 1 to 98       98/99
(98 %)
2 diff
(98.0 %id)
BU781820 insulinoma, Pancreas .e 1606 to 1988 1 to 383   AAA   383/383
(100 %)
5 diff
(98.7 %id)
AA631244 colon, colon tumor RER+ .e 1616 to 1995 399 to 21   AAA   379/379
(100 %)
11 diff
(97.1 %id)
BF589555 Prostate .e 1618 to 1989 378 to 7       372/378
(98 %)
0 diff
(100 %id)
BX338134 Placenta Cot 25-normalized .e 1620 to 1934 339 to 24       316/339
(93 %)
0 diff
(100 %id)
BF092370 testis_normal .e 1623 to 1772 156 to 3       154/156
(98 %)
0 diff
(100 %id)
BE895880 melanotic melanoma, skin .e 1627 to 1992 1 to 367       367/367
(100 %)
1 diff
(99.8 %id)
BU782623 insulinoma, Pancreas .e 1628 to 1995 1 to 368   AAA Submitted on the opposite strand 368/368
(100 %)
2 diff
(99.5 %id)
BU783895 insulinoma, Pancreas .e 1628 to 1995 1 to 368   AAA Submitted on the opposite strand 368/368
(100 %)
2 diff
(99.5 %id)
BU733130 eye, RPE and Choroid .e 1629 to 1988 376 to 17   AAA   360/360
(100 %)
5 diff
(98.7 %id)
BQ478230 insulinoma, Pancreas .e 1631 to 1995 1 to 365   AAA Submitted on the opposite strand 365/365
(100 %)
6 diff
(98.4 %id)
BQ787697 insulinoma, Pancreas .e 1631 to 1995 1 to 365   AAA Submitted on the opposite strand 365/365
(100 %)
2 diff
(99.5 %id)
BQ478479 insulinoma, Pancreas .e 1632 to 1995 409 to 45   AAA Submitted on the opposite strand 365/365
(100 %)
5 diff
(98.7 %id)
DB532575 hippocampus .e 1637 to 1994 1 to 361     Submitted on the opposite strand 361/363
(99 %)
8 diff
(97.8 %id)
AI631324 adenocarcinoma, Pancreas .e 1641 to 1995 356 to 2       355/356
(99 %)
0 diff
(100 %id)
AI688195 colon .e 1656 to 1993 340 to 3       338/340
(99 %)
0 diff
(100 %id)
BG984970 colon_normal .e 1663 to 1808 146 to 1       146/153
(95 %)
2 diff
(98.7 %id)
AA719907 heart .e 1667 to 1989 320 to 4       317/320
(99 %)
0 diff
(100 %id)
AA044278 uterus .e 1667 to 1996 328 to 1   fully sequenced,   328/328
(100 %)
4 diff
(98.8 %id)
BM908194 brain, medulla .e 1676 to 1996 1 to 321   AAA   321/321
(100 %)
6 diff
(98.2 %id)
AA953868 pooled .e 1678 to 1988 311 to 1       311/311
(100 %)
10 diff
(96.8 %id)
EC546162 Prostate .e 1681 to 1792 1 to 111       111/112
(99 %)
6 diff
(94.7 %id)
AA531056 normal prostatic epithelial cells, Prostate .e 1688 to 1995 25 to 332   AAA   308/332
(92 %)
10 diff
(97.0 %id)
BM908228 brain, medulla .e 1689 to 1996 21 to 328   AAA   308/328
(93 %)
6 diff
(98.2 %id)
DB546612 hippocampus .e 1690 to 1996 1 to 307     Submitted on the opposite strand 307/309
(99 %)
1 diff
(99.7 %id)
AW769058 colon, moderately-differentiated adenocarcinoma .e 1690 to 1996 314 to 8       307/314
(97 %)
0 diff
(100 %id)
TI_57162479   .e 1690 to 1988 27 to 322   AAA   296/322
(91 %)
6 diff
(98.2 %id)
W02038 heart .e 1692 to 1988 299 to 1       299/306
(97 %)
8 diff
(97.4 %id)
AI748965 colon .e 1694 to 1986 293 to 1       293/293
(100 %)
0 diff
(100 %id)
DB551583 hippocampus .e 1696 to 1996 1 to 302     Submitted on the opposite strand 302/302
(100 %)
16 diff
(94.8 %id)
AI674371 Prostate .e 1696 to 1987 299 to 8       292/299
(97 %)
0 diff
(100 %id)
AW243826 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1703 to 1995 300 to 8       293/300
(97 %)
0 diff
(100 %id)
AI538053 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1714 to 1993 281 to 1       281/281
(100 %)
3 diff
(99.0 %id)
AI923915 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1725 to 1994 270 to 1       270/270
(100 %)
0 diff
(100 %id)
AW190439 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1726 to 1989 271 to 7       265/271
(97 %)
0 diff
(100 %id)
AI521053 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1728 to 1993 270 to 5       266/272
(97 %)
0 diff
(100 %id)
AW193214 adenocarcinoma, Pancreas .e 1728 to 2000 304 to 32   AAA   273/273
(100 %)
10 diff
(96.4 %id)
AI254713 colon, moderately-differentiated adenocarcinoma .e 1729 to 2000 296 to 25   AAA   272/272
(100 %)
1 diff
(99.7 %id)
AW087234 colon, moderately differentiated adenocarcinoma .e 1729 to 1996 278 to 11   AAA   268/268
(100 %)
0 diff
(100 %id)
AW768760 colon, moderately-differentiated adenocarcinoma .e 1730 to 1988 260 to 1       260/260
(100 %)
1 diff
(99.7 %id)
BU073363 insulinoma, Pancreas .e 1733 to 1995 1 to 263   AAA Submitted on the opposite strand 263/263
(100 %)
2 diff
(99.3 %id)
AW772598 normal epithelium, thyroid .e 1736 to 1972 34 to 270     Submitted on the opposite strand 237/270
(87 %)
7 diff
(97.5 %id)
AA912451 pooled germ cell tumors .e 1743 to 1988 245 to 1       245/245
(100 %)
4 diff
(98.4 %id)
AI878904 brain, frontal lobe .e 1762 to 1917 180 to 25     Submitted on the opposite strand 156/180
(86 %)
0 diff
(100 %id)
T31139 brain .e 1762 to 1984 223 to 1     Submitted on the opposite strand 223/223
(100 %)
0 diff
(100 %id)
W57691 heart .e 1767 to 1992 227 to 1       227/227
(100 %)
3 diff
(98.7 %id)
AI474944 anaplastic oligodendroglioma, brain .e 1769 to 1996 245 to 19   AAA   227/227
(100 %)
3 diff
(98.7 %id)
AI918208 anaplastic oligodendroglioma, brain .e 1769 to 1996 230 to 3       228/230
(99 %)
0 diff
(100 %id)
AI561309 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1780 to 1995 216 to 1       216/216
(100 %)
2 diff
(99.1 %id)
BE866827 adenocarcinoma, colon .e 1785 to 1985 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
BQ268382 insulinoma, Pancreas .e 1786 to 1995 231 to 22   AAA   210/216
(97 %)
1 diff
(99.6 %id)
BQ270325 insulinoma, Pancreas .e 1786 to 1995 8 to 217       210/217
(96 %)
6 diff
(97.3 %id)
CK825433 insulinoma, Pancreas .e 1786 to 1904 119 to 1       119/125
(95 %)
1 diff
(99.2 %id)
AA603591 normal prostate, Prostate .e 1791 to 1988 197 to 1       197/197
(100 %)
3 diff
(98.5 %id)
AI657169 Prostate .e 1791 to 1978 199 to 12       188/199
(94 %)
0 diff
(100 %id)
T23448   .e 1819 to 1994 179 to 4       176/179
(98 %)
0 diff
(100 %id)
F04322 brain, total brain .e 1820 to 1994 175 to 1       175/183
(95 %)
0 diff
(100 %id)
AA904818 pooled .e 1826 to 1977 152 to 1       152/152
(100 %)
1 diff
(99.4 %id)
AA614022 adrenal adenoma, adrenal gland .e 1829 to 1994 170 to 5       166/170
(97 %)
0 diff
(100 %id)
AA905571 pooled .e 1845 to 1990 150 to 5       146/150
(97 %)
0 diff
(100 %id)
AA525537 metastatic prostate bone lesion .e 1848 to 1995 1 to 147   AAA   147/147
(100 %)
7 diff
(95.3 %id)
H06128 whole brain .e 1850 to 1994 157 to 13   AAA   145/145
(100 %)
0 diff
(100 %id)
AA523189 metastatic prostate bone lesion .e 1855 to 1995 7 to 147   AAA   141/147
(95 %)
1 diff
(99.4 %id)
AA594528 colon, colon tumor RER+ .e 1898 to 1995 106 to 9       98/106
(92 %)
0 diff
(100 %id)
GD142032   .e 1920 to 1996 1 to 77       77/90
(85 %)
6 diff
(93.4 %id)
GD158780   .e 1920 to 1991 1 to 72   AAA   72/72
(100 %)
4 diff
(94.5 %id)
GD135611   .e 1921 to 1996 1 to 76       76/89
(85 %)
3 diff
(96.7 %id)
AI801122 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1934 to 1995 62 to 1       62/62
(100 %)
0 diff
(100 %id)
BQ272148 Pancreas, Purified pancreatic islet .f 1 to 554 1 to 555       555/556
(99 %)
36 diff
(93.6 %id)
DB007125 cervix, tumor tissue .f 1 to 305 2 to 306   tiling clone, capped   305/316
(96 %)
3 diff
(99.1 %id)
CB154619 brain .f 3 to 208 1 to 206       206/206
(100 %)
3 diff
(98.6 %id)
DA084919 cerebellum .f 9 to 333 2 to 326   capped   325/325
(100 %)
3 diff
(99.1 %id)
BE383488 brain, neuroblastoma .f 11 to 533 15 to 563       453/565
(80 %)
16 diff
(97.2 %id)
DB478610 hippocampus .f 13 to 436 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
CA495302   .f 25 to 584 1 to 561       561/1004
(55 %)
13 diff
(98.8 %id)
DA582140 lung .f 39 to 387 2 to 350   capped   349/349
(100 %)
1 diff
(99.8 %id)
CR993368 T-Lymphocytes .f 43 to 279 1 to 237       237/238
(99 %)
1 diff
(99.6 %id)
DA068010 cerebellum .f 45 to 535 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
DA560614 heart .f 48 to 392 2 to 347   capped   346/346
(100 %)
5 diff
(98.6 %id)
CR983602 T-Lymphocytes .f 49 to 436 1 to 390       390/390
(100 %)
2 diff
(99.5 %id)
CB142412 Liver .f 62 to 306 1 to 245       245/245
(100 %)
0 diff
(100 %id)
BM914648 amelanotic melanoma, cell line, skin .f 70 to 567 12 to 509       498/1405
(35 %)
33 diff
(97.7 %id)
CB991263 placenta, pre-eclamptic placenta .f 70 to 576 24 to 535       512/728
(70 %)
28 diff
(96.2 %id)
CB991878 placenta, pre-eclamptic placenta .f 70 to 450 24 to 404       381/972
(39 %)
11 diff
(98.9 %id)
ES307723 beard hair, skin .f 71 to 291 1 to 215       215/232
(92 %)
11 diff
(95.3 %id)
BQ226941 large cell carcinoma, lung .f 71 to 570 1 to 503       503/942
(53 %)
3 diff
(99.7 %id)
DB473784 hippocampus .f 72 to 499 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
DA008269 adipose .f 75 to 348 2 to 275   capped   274/274
(100 %)
0 diff
(100 %id)
BI550205 brain, hippocampus .f 85 to 573 1 to 491       491/981
(50 %)
11 diff
(98.9 %id)
CA395412 eye, RPE/choroid .f 88 to 572 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
TI_44169412   .f 90 to 573 89 to 574       486/1064
(45 %)
12 diff
(98.9 %id)
BX338135 Placenta Cot 25-normalized .f 96 to 387 66 to 356       291/356
(81 %)
6 diff
(98.4 %id)
CD556598 brain, Pituitary .f 104 to 512 1 to 411       411/933
(44 %)
17 diff
(98.2 %id)
BF725309 eye, Iris .f 108 to 535 1 to 428       428/428
(100 %)
0 diff
(100 %id)
CR593516 Placenta Cot 25-normalized .f 110 to 1377 1 to 1268 exact tiling clone,   1268/1268
(100 %)
0 diff
(100 %id)
BX360101 Placenta Cot 25-normalized .f 110 to 777 1 to 666   fully sequenced,   666/666
(100 %)
3 diff
(99.6 %id)
BE795631 lung, small cell carcinoma .f 118 to 658 1 to 573       553/1285
(43 %)
43 diff
(96.7 %id)
BM424191 amelanotic melanoma, cell line, skin .f 123 to 450 1 to 328       328/1087
(30 %)
1 diff
(100.0 %id)
EC460461 Prostate .f 147 to 239 1 to 91       91/96
(94 %)
3 diff
(96.9 %id)
BG708720 brain, hypothalamus .f 164 to 830 6 to 665       660/665
(99 %)
17 diff
(97.5 %id)
DA108356 cerebellum .f 165 to 732 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BM544232 ovary (pool of 3) .f 187 to 723 154 to 689       536/1476
(36 %)
47 diff
(96.9 %id)
BQ954482 large cell carcinoma, lung .f 295 to 1027 1 to 742       742/826
(89 %)
12 diff
(98.6 %id)
BX283638 Kidney, renal cell adenocarcinoma .f 308 to 799 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BG425212 Kidney, renal cell adenocarcinoma .f 308 to 979 1 to 673       673/834
(80 %)
4 diff
(99.6 %id)
BG325144 Kidney, renal cell adenocarcinoma .f 309 to 1031 1 to 721       721/721
(100 %)
5 diff
(99.4 %id)
TI_151766493   .f 402 to 1019 100 to 719       620/1357
(45 %)
9 diff
(99.4 %id)
EC492717 Prostate .f 435 to 544 109 to 1       109/109
(100 %)
0 diff
(100 %id)
BE378380 endometrium, adenocarcinoma cell line, uterus .f 452 to 1102 1 to 647       649/647
(100 %)
7 diff
(99.0 %id)
AA397622.
matches multiple genes
  .f 471 to 872 1 to 404     also hits gene yanima 404/404
(100 %)
5 diff
(98.8 %id)
BP362705 thalamus .f 484 to 1066 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
EC537325 Prostate .f 510 to 626 122 to 6       117/122
(95 %)
0 diff
(100 %id)
EC535806 Prostate .f 511 to 626 121 to 7       115/121
(95 %)
1 diff
(99.2 %id)
T05793   .f 511 to 729 1 to 219       219/219
(100 %)
1 diff
(99.6 %id)
T05288   .f 566 to 779 1 to 214       214/214
(100 %)
3 diff
(98.6 %id)
BQ777917 Pancreas, Purified pancreatic islet .f 681 to 1106 1 to 426   fully sequenced,   426/426
(100 %)
0 diff
(100 %id)
BQ354040 head_neck .f 703 to 993 6 to 293       288/293
(98 %)
7 diff
(97.7 %id)
BX360100 Placenta Cot 25-normalized .f 716 to 1354 657 to 19   fully sequenced,   639/657
(97 %)
0 diff
(100 %id)
EC488127 Prostate .f 741 to 822 9 to 95       91/95
(95 %)
7 diff
(92.7 %id)
BU073057 insulinoma, Pancreas .f 751 to 889 1 to 139       139/139
(100 %)
6 diff
(95.7 %id)
BE168727 head_neck .f 755 to 927 1 to 173       173/173
(100 %)
0 diff
(100 %id)
BF825634 head_normal .f 758 to 993 236 to 4     Submitted on the opposite strand 233/237
(98 %)
5 diff
(97.9 %id)
BF825635 head_normal .f 758 to 1014 258 to 5     Submitted on the opposite strand 254/259
(98 %)
3 diff
(98.9 %id)
BF858451 prostate_tumor .f 758 to 1041 8 to 291       284/302
(94 %)
8 diff
(97.4 %id)
EC525236 Prostate .f 785 to 876 1 to 92       92/92
(100 %)
0 diff
(100 %id)
AA379468 skin .f 831 to 933 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BQ271822 Pancreas, Purified pancreatic islet .f 841 to 1407 567 to 1       567/567
(100 %)
1 diff
(99.9 %id)
CN310501 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 849 to 1039 1 to 191       191/191
(100 %)
2 diff
(99.0 %id)
AI250058 adenocarcinoma, Pancreas .f 990 to 1407 419 to 2   tiling clone,   418/420
(99 %)
7 diff
(98.4 %id)
AI872060 ovary, tumor, 5 pooled (see description) .f 997 to 1406 410 to 1       410/410
(100 %)
0 diff
(100 %id)
BQ777616 Pancreas, Purified pancreatic islet .f 1045 to 1405 361 to 1   fully sequenced,   361/361
(100 %)
0 diff
(100 %id)
BX419503 brain, fetal brain .g 1 to 897 1 to 895   tiling clone,   895/895
(100 %)
3 diff
(99.7 %id)
DA732698   .g 3 to 483 2 to 482   tiling clone, capped   481/481
(100 %)
7 diff
(98.6 %id)
BX425059 placenta .g 90 to 811 1 to 719   tiling clone,   719/719
(100 %)
8 diff
(98.9 %id)
TI_154046909   .g 634 to 1556 986 to 84   AAA   903/995
(90 %)
30 diff
(97.0 %id)
CD723142 eye, lacrimal gland .g 769 to 1358 1 to 590   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
CA412567 Chondrosarcoma Grade II, Left Pelvis .g 919 to 1556 656 to 19   AAA   638/638
(100 %)
2 diff
(99.7 %id)
BX435125 brain, fetal brain .g 948 to 1562 616 to 1   tiling clone,   616/674
(91 %)
20 diff
(97.1 %id)
BF827029 head_normal .g 951 to 1363 26 to 437       412/440
(93 %)
13 diff
(97.1 %id)
BF092413 testis_normal .g 952 to 1352 407 to 7       401/407
(98 %)
0 diff
(100 %id)
BX453918 placenta .g 976 to 1559 584 to 1       584/662
(88 %)
10 diff
(98.5 %id)
AI954055 normal epithelium, ovary .g 999 to 1564 559 to 1       559/697
(80 %)
16 diff
(97.8 %id)
DB364294   .g 1209 to 1564 354 to 1   tiling clone,   354/354
(100 %)
16 diff
(95.5 %id)
BE882586 leiomyosarcoma, uterus .h 1 to 625 1 to 629   tiling clone,   629/880
(71 %)
8 diff
(99.1 %id)
TI_977333959   .h 561 to 1335 1 to 775   tiling clone, fully sequenced,   775/775
(100 %)
10 diff
(98.8 %id)
DT932761 pooled .h 580 to 1333 1 to 754       754/754
(100 %)
7 diff
(99.1 %id)
DT932762 pooled .h 597 to 1065 702 to 234     Submitted on the opposite strand 469/702
(66 %)
1 diff
(99.9 %id)
BF092405 testis_normal .h 637 to 764 150 to 23       128/150
(85 %)
1 diff
(99.4 %id)
TI_977333960   .h 735 to 1060 591 to 266   tiling clone, fully sequenced,   326/591
(55 %)
0 diff
(100 %id)
CN315386 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i-u 1 to 608 4 to 612   tiling clone,   609/612
(99 %)
6 diff
(99.1 %id)
CN290857 embryonic stem cells, DMSO-treated H9 cellline .i-u 347 to 678 1 to 332   tiling clone,   332/332
(100 %)
1 diff
(99.7 %id)
BI908289 leukocyte .i-u 629 to 1236 118 to 740   tiling clone,   623/845
(73 %)
37 diff
(95.7 %id)
TI_57234434   .i-u 629 to 1236 152 to 774       623/879
(70 %)
37 diff
(95.8 %id)
AW163073 brain, frontal lobe .i-u 808 to 1254 446 to 1   tiling clone,   446/447
(99 %)
10 diff
(97.8 %id)
BG421819 Kidney, renal cell adenocarcinoma .j 1 to 686 1 to 689   tiling clone,   689/692
(99 %)
10 diff
(98.6 %id)
TI_57238986   .j 2 to 718 28 to 752   tiling clone, AAA   725/1055
(68 %)
19 diff
(98.2 %id)
BG387140 adenocarcinoma cell line, colon .j 4 to 706 1 to 703       703/703
(100 %)
10 diff
(98.6 %id)
CF128622 Chondrosarcoma Lung Metastasis cell lines, lung .j 17 to 699 1 to 683   tiling clone,   683/683
(100 %)
3 diff
(99.6 %id)
BF311636 brain, neuroblastoma .j 21 to 735 1 to 717 Q92P P93A R94Q L95T E96G ... tiling clone,   719/946
(76 %)
16 diff
(98.4 %id)
BM920831 pooled brain, lung, testis .k 1 to 763 20 to 787 L19R G182R L183P A184R L185P ... tiling clone,   768/1106
(69 %)
24 diff
(97.9 %id)
DB475674 hippocampus .l-u -8 to 457 1 to 466 S88* tiling clone,   466/466
(100 %)
1 diff
(99.8 %id)
CN310504 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l-u 44 to 335 1 to 292   tiling clone,   292/292
(100 %)
2 diff
(99.4 %id)
BM048145 carcinoma, cell line, Prostate .m 1 to 891 1 to 875 L19W E20S L21W G22A L23S ... tiling clone,   875/875
(100 %)
60 diff
(93.2 %id)
BI918359 brain .n 1 to 597 1 to 597 exact tiling clone,   597/597
(100 %)
0 diff
(100 %id)
TI_57243130   .n 1 to 597 31 to 627 exact     597/627
(95 %)
6 diff
(99.1 %id)
BM913274 amelanotic melanoma, cell line, skin .n 19 to 570 1 to 552 exact     552/1254
(44 %)
2 diff
(99.9 %id)
BM916459 amelanotic melanoma, cell line, skin .n 19 to 729 1 to 715 K109E E110G S111V G112W H113T ... tiling clone,   715/1176
(60 %)
15 diff
(98.8 %id)
BQ271228 Pancreas, Purified pancreatic islet .o 1 to 420 1 to 420   tiling clone, fully sequenced,   420/420
(100 %)
4 diff
(99.1 %id)
BQ270932 Pancreas, Purified pancreatic islet .o 390 to 797 408 to 1   tiling clone, fully sequenced,   408/408
(100 %)
4 diff
(99.1 %id)
AI824541 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o 519 to 800 282 to 1   tiling clone,   282/282
(100 %)
0 diff
(100 %id)
BG746214 Spleen .p-u 1 to 490 495 to 4 S2A L11Q L18C P19L S20L ... tiling clone,   492/1010
(48 %)
0 diff
(100 %id)
BF094634 uterus_tumor .q 1 to 361 1 to 361 H90Q tiling clone,   361/361
(100 %)
3 diff
(99.2 %id)
BI523328 brain .r 1 to 645 684 to 23 P18T R19P P20T G21R K22G ... tiling clone,   662/684
(96 %)
4 diff
(99.5 %id)
TI_44185807   .r 1 to 645 684 to 23 P18T R19P P20T G21R K22G ...     662/684
(96 %)
4 diff
(99.5 %id)
AI610084 brain, tumor, 5 pooled (see description) .s 1 to 335 335 to 1 exact tiling clone,   335/335
(100 %)
1 diff
(99.8 %id)
DA620256   .t-u 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
AI681151 carcinoid, lung .u-u 1 to 355 364 to 10 exact tiling clone, AAA   355/355
(100 %)
3 diff
(99.2 %id)
AI698026 carcinoid, lung .u-u 1 to 356 364 to 9 exact     356/364
(97 %)
0 diff
(100 %id)
AW291413   .u-u 21 to 353 345 to 13 exact tiling clone,   333/348
(95 %)
0 diff
(100 %id)
AW449821   .u-u 21 to 353 345 to 13 exact     333/348
(95 %)
0 diff
(100 %id)
BI030206 marrow .u-u 31 to 392 1 to 362 exact tiling clone,   362/362
(100 %)
7 diff
(98.1 %id)
EC582752 Prostate .va 1 to 108 108 to 1 A28P W29G R31P P32T P33H ...     108/108
(100 %)
2 diff
(98.2 %id)
EC582886 Prostate .va 1 to 108 108 to 1 exact tiling clone,   108/109
(99 %)
0 diff
(100 %id)
BP214036 cerebrum Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
BP217204 corpus callosum Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
DB497447 hypothalamus Gene NPDC1andFUT7, variant not shown         This clone was ignored    
AV726609 hypothalamus Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
N49760 multiple sclerosis lesions Gene NPDC1andFUT7, variant not shown         This clone was ignored    
N52689 multiple sclerosis lesions Gene NPDC1andFUT7, variant not shown         This clone was ignored    
AA804268 germinal center B cell Gene NPDC1andFUT7, variant not shown         This clone was ignored    
AA765364 germinal center B cell Gene NPDC1andFUT7, variant not shown         This clone was ignored    
AA767713 germinal center B cell Gene NPDC1andFUT7, variant not shown         This clone was ignored    
AI139320 uterus Gene NPDC1andFUT7, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
BG705006 brain, hippocampus Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
BU163516 ductal carcinoma, cell line, Pancreas Gene NPDC1andFUT7, variant not shown       AAA This clone was ignored    
BQ690062 ductal carcinoma, cell line, Pancreas Gene NPDC1andFUT7, variant not shown       AAA This clone was ignored    
BQ685619 ductal carcinoma, cell line, Pancreas Gene NPDC1andFUT7, variant not shown       AAA This clone was ignored    
BM825622 stomach Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
BM831121 stomach Gene NPDC1andFUT7, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l-u, .m, .n, .o, .p-u, .q, .r, .s, .t-u, .u-u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI